EORTC-55994-GCG

Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs. concomitant radiotherapy and chemotherapy in FIGO Ib2, IIa > 4 cm or IIb cervical cancer.
Study documentation
Trial StatusClosed for recruitment
DatesDate of activation: 19-Mar-02
Closed on : 01-Jul-14
Data management at EORTCFull
Phase3
Randomized trial
Type-
Targeted Sample sizeEORTC Groups: 625 - All Groups: 625
Number of steps1
DrugCisplatin
Study StaffStefano Greggi
Study Coordinator - Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli
Gemma Kenter
Study Coordinator - Academisch Medisch Centrum - Universiteit van Amsterdam, Amsterdam
Fabio Landoni
Study Coordinator - Istituto Europeo di Oncologia, Milano
Corneel Coens
Statistician - EORTC Headquarters, Brussels
Maarten De Rouck
Data Manager - EORTC Headquarters, Brussels
maarten.derouck (at) eortc.be - +32 27741660
Ellen Peeters
Project Manager - EORTC Headquarters, Brussels
ellen.peeters (at) eortc.be - +32 27741082
Type of cancerCervical
Participating GroupsEORTC Gynecological Cancer Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT numberNCT00039338
EudraCT2008-003396-52